Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can Low-Oxygen training supercharge lung cancer therapy?

NCT ID NCT07618793

Not yet recruiting Disease control Sponsor: zhang yi Source: ClinicalTrials.gov ↗

First seen Jun 01, 2026 · Last updated Jun 13, 2026 · Updated 5 times

Summary

This study tests whether adding short sessions of low-oxygen breathing (intermittent hypoxic training) to standard chemotherapy and immunotherapy can help shrink lung tumors more effectively. About 60 adults with stage II-IIIA lung squamous cell carcinoma will receive either standard treatment alone or standard treatment plus the breathing training. The goal is to see if the combination leads to a complete disappearance of cancer cells in the removed tumor and improves long-term survival without major side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Xuanwu Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100053, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CARCINOMA, NON-SMALL-CELL LUNG (NSCLC) LUNG SQUAMOUS CELL CARCINOMA

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

RESECTABLE STAGE II-IIIA LUNG SQUAMOUS CELL CARCINOMA